Survival Advantage of Abiraterone Acetate (Zytiga) in Men with Castrate Resistant Metastatic Advanced Prostate Cancer
We all know that abiraterone acetate (Zytiga) plus prednisone provides a survival advantage for men with castrate resistant advanced prostate cancer (mCRPC) who have had prior treatment with a taxane based chemotherapy. New information has [...]
Taxane-Based Chemotherapy Drugs May Be Underestimated, Especially Against Advanced Prostate Cancer
According to researchers at Weill Cornell Medical College in the Sept. 15 issue of the journal Cancer Research, taxne-based chemotherapy drugs are not well understood as they may be more powerful than many have believed. [...]
More Information About C11 Choline Scans & Some of the Other Alternative Scans Used to ID Focal Advanced Prostate Cancer Recurrences
Off-line I have received a number of additional questions about the use of imaging with c11 choline (see my post at http://advancedprostatecancer.net/?p=3433). The questions ranged from what is c11 choline to how it compares to [...]
A Great Stride In PET Imaging, But Not A Panacea – C11 Choline For Diagnosing Recurrent Prostate Cancer
The FDA has approved c11 choline Injection, a Positron Emission Tomography (PET) imaging agent, for use in men to detect prostate cancer recurrences and to locate specific body sites for follow-up tissue sampling, testing and [...]
So Much Has Happened While I was Away – News About Advanced Prostate Cancer
The summer is coming to a close and I am back, ready to again take on the world. I had the fantastic opportunity of spending almost two weeks in Alaska, a land that is so [...]
Getting Early Access Now to Alpharedin (radium-233 chloride) NOW – We Need Your HELP
Our Prostate Cancer community was happy when Bayer and Algeta announced an Early/Expanded Access Program for Alpharedin. However we notice that, as of today, there is only one clinical trial site that is currently open [...]